decreasing of economic status and consumption product resulting the total revenue and net profit of the Company is decreased. In 2017, the Company has total revenue of THB 294 Million decreasing from THB 322
)] = 1.01 shares/ 1 warrant Where Price 1 = Exercise Price after the change Price 0 = Exercise Price prior the change Ratio 1 = Exercise Ratio after the change Ratio 0 = Exercise Ratio prior the change MP
Management Discussion and Analysis Quarter 2 Ending 30 June 2019 Appendix Unit : Million Baht 2nd Quarter 2019 2nd Quarter 2018 % Variance Income Revenue from sale of goods 3,928 7,815 (50%) Net foreign
% EBITDA margin 21.0% 20.2% 0.8% 21.2% -0.2% Net profit margin for the period 14.1% 13.1% 1.0% 12.6% 1.5% Net profit margin attributable to the owners of the parent 14.0% 12.8% 1.2% 12.5% 1.5% Key Change in
= Translation = Management Discussion and Analysis for Interim Business Operations The Information of Share Capital Registration and Entire Business Transfer The Company registered the change of
company and its subsidiaries’ operating result for the 1st quarter ended 31st March 2020 Unit: THB Million Q1/2020 Q4/2019 QoQ Q1/2019 YoY Total Revenue 43,070 50,146 -14% 45,535 -5% Accounting EBITDA
policy 2019 2018 2019 2018 Transactions with the intermediate parent company Revenue from advertising production 2,515 - - - Contract rate Revenue from system installation services 6,429 - - - Contract
www.interpharma.co.th IP_OCS/011/2020 8th June 2020 Subject: Notify the Resolutions of the Board of Directors Meeting, Change of Objectives of Funds Usage, Acquisition of Assets, The Issuance of Debentures and Fix the
% compared to the same period of previous year. Total Apparent Finished Steel (Unit : Tons) Quarter 3/2016 Quarter 3/2017 % Change Production 1,531,203 1,696,674 10.81% Import 3,242,891 2,843,598 -12.31
structural change in the business outlook of PET, and is an oppor- tunity for well-managed and committed PET producers like IVL to align supply reliability to customers. We benefitted from the instability